[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337534-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337534-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","joint-analysis-of-mutational-and-transcriptional-landscapes-in-human-cancer-reveals-key-perturbations-during-cancer-evolution","Joint analysis of mutational and transcriptional landscapes in human cancer reveals key perturbations during cancer evolution","","Tumors acquire new capabilities such as drug resistance and metastasis that worsen clinical outcomes. Although single-cell technologies enable joint study of mutational and transcriptionomic profiles, human-patient cancer evolution remains poorly characterized because many studies focus on model systems. This work jointly analyzes single-cell mutational and transcriptomic data from lung cancer and chronic myeloid leukemia biopsies to map clonal selection, transcriptional state coupling, and tumor-microenvironment–related perturbations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/joint-analysis-of-mutational-and-transcriptional-landscapes-in-human-cancer-reveals-key-perturbations-during-cancer-evolution/337534/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/joint-analysis-of-mutational-and-transcriptional-landscapes-in-human-cancer-reveals-key-perturbations-during-cancer-evolution/337534.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in cancer research?","Question",{"text":63,"@type":64},"It investigates how mutational and transcriptional landscapes interact during cancer evolution in human patients, a topic limited by prior studies focused mainly on model systems.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were clonal selection and evolution analyzed?",{"text":68,"@type":64},"The study jointly analyzes mutational and transcriptomic profiles from single cells obtained from tumor biopsies across lung cancer and chronic myeloid leukemia samples.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationships were found between mutations, transcriptional changes, and drug resistance?",{"text":72,"@type":64},"Each clone is linked to a preferred transcriptional state; as clones evolve, mutations in genes related to metastasis and drug resistance increase, while gene-expression changes remain limited. Mutations affecting ligand–receptor interactions with the tumor microenvironment frequently emerge with acquired drug resistance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337534,1790315943,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Cho et al. Genome Biology (2024) 25:65 Genome Biology  \n[https://doi.org/10.1186/s13059-024-03201-1](https://doi.org/10.1186/s13059-024-03201-1)  \nRESEARCH Open Access  \nJoint analysis of mutational and transcriptional   landscapes in human cancer reveals key perturbations during cancer evolution  \nJae‑Won Cho 1, Jingyi Cao1 and Martin Hemberg1*  \n*Correspondence: [mhemberg@bwh.harvard.edu](mhemberg@bwh.harvard.edu)  \n1 The Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA  \nAbstract  \nBackground: Tumors are able to acquire new capabilities, including traits such as drug resistance and metastasis that are associated with unfavorable clinical outcomes. Single‑cell technologies have made it possible to study both mutational and tran‑ scriptomic profiles, but as most studies have been conducted on model systems, little is known about cancer evolution in human patients. Hence, a better understanding of cancer evolution could have important implications for treatment strategies.  \nResults: Here, we analyze cancer evolution and clonal selection by jointly consider‑ ing mutational and transcriptomic profiles of single cells acquired from tumor biopsies from 49 lung cancer samples and 51 samples with chronic myeloid leukemia. Compar‑ ing the two profiles, we find that each clone is associated with a preferred transcrip‑ tional state. For metastasis and drug resistance, we find that the number of mutations affecting related genes increases as the clone evolves, while changes in gene expres‑ sion profiles are limited. Surprisingly, we find that mutations affecting ligand‑receptor interactions with the tumor microenvironment frequently emerge as clones acquire drug resistance.  \nConclusions: Our results show that lung cancer and chronic myeloid leukemia maintain a high clonal and transcriptional diversity, and we find little evidence in favor of clonal sweeps. This suggests that for these cancers selection based solely on growth rate is unlikely to be the dominating driving force during cancer evolution.  \nKeywords: Cancer evolution, Clonal selection, Genetic‑transcription perturbation, Metastasis, Drug resistance, Metabolism, Tumor microenvironment  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the mate‑ rial. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://](http://)[ ](http://)[creativecommons.org/licenses/by/4.0/](creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativecommons.org/publicdo](http://creativecommons.org/publicdo)‑ main/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nBackground  \nCancer is characterized by the accumulation of somatic mutations, resulting in distinct clones. The clonal composition of a tumor changes over time, and this evolution is oneof the mechanisms by which new characteristics can be acquired during cancer progression [1–3]. Although evolution is gradual over short time scales, over longer times, more dramatic alterations may occur. New clones","cbCaisZjCiDY2odt","https://ap.wps.com/l/cbCaisZjCiDY2odt","pdf",3355675,23,"English","# Abstract\n## Background\n## Results\n## Conclusions\n# Background\n# Single-cell technologies and prior approaches\n# Study shortcomings","[{\"question\":\"What problem does the study address in cancer research?\",\"answer\":\"It investigates how mutational and transcriptional landscapes interact during cancer evolution in human patients, a topic limited by prior studies focused mainly on model systems.\"},{\"question\":\"How were clonal selection and evolution analyzed?\",\"answer\":\"The study jointly analyzes mutational and transcriptomic profiles from single cells obtained from tumor biopsies across lung cancer and chronic myeloid leukemia samples.\"},{\"question\":\"What relationships were found between mutations, transcriptional changes, and drug resistance?\",\"answer\":\"Each clone is linked to a preferred transcriptional state; as clones evolve, mutations in genes related to metastasis and drug resistance increase, while gene-expression changes remain limited. Mutations affecting ligand–receptor interactions with the tumor microenvironment frequently emerge with acquired drug resistance.\"}]","Joint analysis of mutational and transcriptional landscapes in human cancer reveals key perturbations during cancer evolution | PDF",1790019537,58,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1754d16d0e5df6d1deabd9516fcc91a.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d6ea17bc679e4d42ff9e5eb290023fa.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59e0c487e8b2e58129849b6b33776b73.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39c1e02efdb91a4ca965a3a854eadaa5.webp",980,1301]